Your browser is no longer supported. Please, upgrade your browser.
Settings
SNSS [NASD]
Sunesis Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.73 Insider Own0.40% Shs Outstand67.73M Perf Week-5.41%
Market Cap165.94M Forward P/E- EPS next Y-0.36 Insider Trans0.00% Shs Float67.19M Perf Month10.36%
Income-43.00M PEG- EPS next Q-0.16 Inst Own77.00% Short Float6.30% Perf Quarter-3.92%
Sales5.70M P/S29.11 EPS this Y-9.10% Inst Trans-17.71% Short Ratio3.91 Perf Half Y-68.02%
Book/sh0.22 P/B11.14 EPS next Y41.00% ROA-77.50% Target Price3.38 Perf Year-62.93%
Cash/sh0.63 P/C3.86 EPS next 5Y- ROE-291.50% 52W Range1.00 - 8.46 Perf YTD-3.92%
Dividend- P/FCF- EPS past 5Y42.80% ROI-195.20% 52W High-71.04% Beta2.33
Dividend %- Quick Ratio1.60 Sales past 5Y8.40% Gross Margin- 52W Low145.00% ATR0.15
Employees39 Current Ratio1.60 Sales Q/Q-55.00% Oper. Margin- RSI (14)53.02 Volatility6.38% 7.27%
OptionableYes Debt/Eq0.67 EPS Q/Q84.60% Profit Margin- Rel Volume0.72 Prev Close2.47
ShortableYes LT Debt/Eq0.00 EarningsMay 07 BMO Payout- Avg Volume1.08M Price2.45
Recom2.50 SMA203.29% SMA504.37% SMA200-39.03% Volume772,593 Change-0.81%
Dec-15-14Upgrade ROTH Capital Neutral → Buy $2.30 → $4.30
Dec-09-14Reiterated ROTH Capital Neutral $1.30 → $2.30
Oct-07-14Downgrade ROTH Capital Buy → Neutral $15 → $1.30
Oct-07-14Downgrade RBC Capital Mkts Outperform → Sector Perform $9 → $3
Jun-12-14Initiated UBS Buy $14
Sep-11-12Reiterated Cantor Fitzgerald Buy $6 → $8
May-29-12Upgrade RBC Capital Mkts Sector Perform → Outperform $3 → $5
Apr-13-12Initiated Cantor Fitzgerald Buy $6
Mar-06-12Initiated Canaccord Genuity Buy $4
Oct-11-11Downgrade RBC Capital Mkts Outperform → Sector Perform $4 → $3
Sep-29-11Initiated MLV Capital Buy $3.50
Mar-24-15 02:13PM  4 Biotech Stocks Under $10 to Trade for Breakouts at TheStreet
Mar-23-15 03:15PM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Mar-19-15 01:04PM  SUNESIS PHARMACEUTICALS INC Financials +9.09%
Mar-12-15 04:48PM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and +6.42%
11:00AM  Sunesis Pharmaceuticals Inc Earnings Call scheduled for 11:00 am ET today
08:11AM  Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Recent Highlights at noodls
07:27AM  Sunesis reports 4Q loss
07:07AM  Q4 2014 Sunesis Pharmaceuticals Inc Earnings Release - Before Market Open
07:00AM  Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Recent Highlights GlobeNewswire
Mar-05-15 01:42PM  3 Biotech stocks Under $10 to Trade for Breakouts at TheStreet +6.02%
07:00AM  Sunesis to Host Conference Call on March 12th to Discuss Fourth Quarter and Full-Year 2014 Financial Results and Recent Highlights GlobeNewswire
Mar-02-15 09:07AM  Sunesis Announces Amendment to Loan Agreement at noodls
07:00AM  Sunesis Announces Amendment to Loan Agreement GlobeNewswire
Feb-24-15 07:27AM  Sunesis to Present at Upcoming Investor Conferences at noodls
07:00AM  Sunesis to Present at Upcoming Investor Conferences GlobeNewswire
Feb-19-15 01:23PM  4 Health Care Stocks Under $10 to Watch: ImmunoGen, Bacterin and More at TheStreet
Feb-18-15 07:00AM  Sunesis to Present at the 2015 RBC Capital Markets' Global Healthcare Conference GlobeNewswire +7.17%
Feb-03-15 09:15AM  The Life Sciences Report Releases 2015 Small-Cap Biotech Watchlist Panel Comments Marketwired
Jan-05-15 07:19PM  BTIG Initiates Coverage On Sunesis Pharmaceuticals, Believes Company 'Will Be Breakeven By 2017' Benzinga
Dec-16-14 01:04PM  SUNESIS PHARMACEUTICALS INC Financials EDGAR Online Financials +6.33%
Dec-15-14 05:46AM  Sunesis Pharma upgraded by ROTH Capital Briefing.com
Dec-09-14 01:30PM  Sunesis Pharmaceuticals Inc to Discuss Presentation of Phase 3 VALOR Trial Results at ASH Annual Meeting scheduled for 1:30 pm ET today CCBN
Dec-08-14 01:30PM  Sunesis Announces Presentation of Positive Updated Results from Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS at ASH Annual Meeting GlobeNewswire
Dec-07-14 05:28PM  Sunesis Spin Doctor Tiptoes Around Failed Leukemia Drug Trial at TheStreet
12:30PM  Sunesis Pharmaceuticals Announces Presentation of Results From Phase 3 VALOR Trial at ASH Annual Meeting GlobeNewswire
Dec-02-14 11:00AM  Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off at TheStreet
07:00AM  Sunesis Pharmaceuticals to Host Conference Call and Slide Webcast Tuesday, December 9 Following Presentation of Phase 3 VALOR Trial Results at ASH Annual Meeting GlobeNewswire
Nov-24-14 07:00AM  Sunesis Announces Publication of REVEAL-1 Trial Results in the British Journal of Haematology GlobeNewswire +6.60%
Nov-19-14 07:00AM  Sunesis Announces Publication of Vosaroxin Phase 1b/2 AML Trial Results in Haematologica GlobeNewswire
Nov-18-14 07:17AM  Sunesis Pharmaceuticals (SNSS) Jumps: Stock Surges 38.3% Zacks -10.39%
Nov-17-14 01:55PM  Is This the Sunesis Resurrection? at 24/7 Wall St. +38.32%
01:51PM  Sunesis Pharmaceuticals Bounces On Results Announcement at TheStreet
11:54AM  Sunesis Pharmaceuticals (SNSS) Stock Surges on Upcoming Announcement of Blood Cancer Treatment Data at TheStreet
09:05AM  Sunesis Pharmaceuticals Announces Late-Breaking Presentation of Phase 3 VALOR Trial at ASH Annual Meeting GlobeNewswire
Nov-12-14 07:09PM  10-Q for Sunesis Pharmaceuticals, Inc. Company Spotlight
Nov-10-14 10:30AM  Sunesis Pharmaceuticals Inc Earnings Call scheduled for 10:30 am ET today CCBN
08:02AM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online
07:00AM  Sunesis Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent Highlights GlobeNewswire
Nov-05-14 07:00AM  Sunesis to Present at Upcoming Investor Conferences GlobeNewswire
Nov-03-14 07:00AM  Sunesis to Host Conference Call on November 10th to Discuss Third Quarter 2014 Financial Results and Recent Highlights GlobeNewswire
Oct-24-14 12:03PM  Ken Griffin has loaded up on Angie's List at MarketWatch +19.58%
Oct-22-14 12:23PM  Citadel Advisors adds to its position in Sunesis Pharmaceuticals Market Realist
Oct-15-14 08:29AM  Sunesis Pharmaceuticals (SNSS) Jumps: Stock Gains 8.5% Zacks +7.83%
Oct-09-14 08:31AM  The Zacks Analyst Blog Highlights: Sunesis Pharmaceuticals, Chimerix, Regeneron and Incyte Zacks -13.29%
Oct-08-14 07:14AM  Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update Zacks +5.93%
Oct-07-14 04:19PM  Sunesis Pharmaceuticals, Inc.'s Flop: More Drugs Out There, Says Roth Benzinga -7.53%
03:40PM  Sunesis Pharmaceuticals Down on Failure of Trial on Qinprezo Zacks
11:39AM  It's True, Small-Cap Biotech Stocks Are Acting Badly These Days at TheStreet
08:29AM  Mondays Notable Options Activity: WhatsApp with Facebook? Yahoo Finance Blogs
Oct-06-14 02:00PM  U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement Of Acquisition By Becton, Dickinson Benzinga -78.01%
12:46PM  Midday movers: Chimerix, H&R Block, McDonald's & More at CNBC
11:54AM  [video] Stocks Push Back After Opening Higher, Nasdaq Erases Gains at TheStreet
11:31AM  Why Sunesis Pharmaceuticals (SNSS) Stock Hit a One-Year Low Today at TheStreet
10:58AM  Markets Open Higher; Hewlett-Packard Plans To Split Into Two Companies Benzinga
08:46AM  US STOCKS-Small biotech stocks plummet in premarket Reuters
08:41AM  A one-day fling for stocks, and fret more over gold than over the dollar at MarketWatch
08:28AM  Ahead of the Bell: Sunesis Pharma shares sink AP
07:41AM  Sunesis Pharma shares crater after failed cancer drug trial at MarketWatch
07:00AM  Sunesis Drug for Elderly Blood Cancer Patients Fails Phase III Study at TheStreet
06:37AM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
06:30AM  Sunesis Announces Results From Pivotal Phase 3 VALOR Trial of Vosaroxin and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia GlobeNewswire
Sep-04-14 07:00AM  Sunesis to Present at the 2014 Morgan Stanley Global Healthcare Conference GlobeNewswire
Sep-02-14 10:29AM  Sunesis Takes a Run Through the Feuerstein-Ratain Rule at TheStreet
Aug-28-14 06:43AM  Sunesis Pharmaceuticals (SNSS) in Focus: Stock Rises 9.9% Zacks -5.47%
Aug-27-14 04:05PM  UBS Says Sunesis Leukemia Pivotal Trial Success 'Likely' Benzinga +9.88%
Aug-26-14 10:02AM  Weak On High Volume: Sunesis Pharmaceuticals (SNSS) at TheStreet
09:50AM  Your September Biotech Back-to-School Calendar at TheStreet
Aug-06-14 08:19AM  Sunesis Pharmaceuticals, Inc. (SNSS) Jumps: Stock Rises 9% Zacks
07:00AM  Sunesis to Present at the 2014 Wedbush Life Sciences Management Access Conference GlobeNewswire
Aug-05-14 11:00AM  Sunesis Pharmaceuticals Inc Earnings Call scheduled for 11:00 am ET today CCBN +9.02%
08:02AM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online
07:07AM  Q2 2014 Sunesis Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
07:00AM  Sunesis Pharmaceuticals Reports Second Quarter 2014 Financial Results and Recent Highlights GlobeNewswire
Jul-29-14 07:00AM  Sunesis to Host Conference Call on August 5th to Discuss Second Quarter 2014 Financial Results and Recent Highlights GlobeNewswire
Jul-14-14 05:45PM  Sunesis' Pediatric Plan Accepted in the EU Zacks
Jul-09-14 08:42AM  Better Buy: Clovis Oncology vs. Sunesis Pharmaceuticals at Motley Fool
07:04AM  Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo For AML Benzinga
07:00AM  Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo(TM) (Vosaroxin) for AML GlobeNewswire
Jun-13-14 07:11AM  Sunesis Pharmaceuticals (SNSS) Soars: Stock Adds 8% in Session Zacks
Jun-12-14 09:13AM  On The Fly: Pre-market Movers at theflyonthewall.com +7.96%
Jun-11-14 07:00AM  Sunesis to Present at the 2014 Wells Fargo Healthcare Conference GlobeNewswire
Jun-09-14 04:24PM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Jun-02-14 07:16AM  Sunesis says encouraged by trial of Qinprezo at theflyonthewall.com
07:00AM  Sunesis Announces Presentation of Positive Updated Results From Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS at ASCO 2014 Annual Meeting GlobeNewswire
May-14-14 07:00AM  Sunesis to Present at Upcoming Investor Conferences GlobeNewswire
May-09-14 11:14AM  Sunesis Pharmaceuticals Inc Stock Downgraded (SNSS) at TheStreet +5.25%
May-08-14 06:52AM  Is Sunesis Pharmaceuticals Poised for a Breakout? at Motley Fool
May-07-14 02:00PM  Sunesis Pharmaceuticals' (SNSS) CEO Daniel Swisher on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
11:00AM  Sunesis Pharmaceuticals, Inc. Earnings Call scheduled for 11:00 am ET today CCBN
08:03AM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online
07:07AM  Q1 2014 Sunesis Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
07:00AM  Sunesis Pharmaceuticals Reports First Quarter 2014 Financial Results and Recent Highlights GlobeNewswire
Apr-30-14 07:00AM  Sunesis to Host Conference Call on May 7th to Discuss First Quarter 2014 Financial Results and Recent Highlights GlobeNewswire
Apr-29-14 06:31PM  3 Ways Ariad Pharmaceuticals Could Mount a Comeback at Motley Fool
Apr-22-14 07:00AM  Sunesis Announces MD Anderson Sponsored Study of Vosaroxin in AML and High-Risk MDS Poster to be Presented at ASCO 2014 GlobeNewswire +8.16%
Apr-10-14 06:31PM  2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals at Motley Fool -8.75%
Apr-08-14 01:30PM  Sunesis vosaroxin shown to be effective, says Wedbush at theflyonthewall.com
11:00AM  Sunesis Pharmaceuticals Update Call to Discuss Poster Presented at the AACR Annual Meeting scheduled for 11:00 am ET today CCBN
08:00AM  Sunesis Announces Presentation of Positive Results From Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS GlobeNewswire
Apr-07-14 11:17AM  Is Now the Time to Invest in Agios Pharmaceuticals, Inc? at Motley Fool
Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The company is developing vosaroxin, an anti-cancer quinolone derivative for the treatment of acute myeloid leukemia (AML). It has completed a Phase III, randomized, double-blind, and placebo-controlled trial of vosaroxin in combination with cytarabine in patients with relapsed or refractory AML. The company also completed a Phase II single-agent trial of vosaroxin in platinum-resistant ovarian cancer. In addition, it is involved in the initiation of an investigator-sponsored trial of vosaroxin in combination with decitabine in older patients with untreated AML and high-risk myelodysplastic syndrome. Sunesis Pharmaceuticals, Inc. has a collaboration agreement with Biogen Idec to discover, develop, and commercialize small molecule inhibitors of the human protein Raf kinase; and licensing agreements with Millennium to provide worldwide license to develop and commercialize preclinical inhibitors of phosphoinositide-dependent kinase-1. The company was founded in 1998 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BASKETT FOREST10% OwnerAug 29Sale7.5111,60087,0704,659,333Aug 29 05:39 PM
BARRETT M JAMES10% OwnerAug 29Sale7.5111,60087,0704,659,333Aug 29 05:38 PM
Growth Equity Opportunities Fu10% OwnerAug 29Sale7.5111,60087,0704,659,333Aug 29 05:37 PM
KERINS PATRICK J10% OwnerAug 29Sale7.5111,60087,0704,659,333Aug 29 05:41 PM
KOLLURI KRISHNA KITTU10% OwnerAug 29Sale7.5111,60087,0704,659,333Aug 29 05:41 PM
DRANT RYAN D10% OwnerAug 29Sale7.5111,60087,0704,659,333Aug 29 05:40 PM
BARRIS PETER J10% OwnerAug 29Sale7.5111,60087,0704,659,333Aug 29 05:39 PM
BARRIS PETER J10% OwnerAug 28Sale7.87146,8001,154,8464,670,933Aug 29 05:39 PM
DRANT RYAN D10% OwnerAug 28Sale7.87146,8001,154,8464,670,933Aug 29 05:40 PM
KOLLURI KRISHNA KITTU10% OwnerAug 28Sale7.87146,8001,154,8464,670,933Aug 29 05:41 PM
KERINS PATRICK J10% OwnerAug 28Sale7.87146,8001,154,8464,670,933Aug 29 05:41 PM
Growth Equity Opportunities Fu10% OwnerAug 28Sale7.87146,8001,154,8464,670,933Aug 29 05:37 PM
BARRETT M JAMES10% OwnerAug 28Sale7.87146,8001,154,8464,670,933Aug 29 05:38 PM
BASKETT FOREST10% OwnerAug 28Sale7.87146,8001,154,8464,670,933Aug 29 05:39 PM
Misfeldt DaytonDirectorAug 28Sale7.89200,0001,577,02085,872Aug 29 06:31 PM
BAY CITY CAPITAL LLC10% OwnerAug 28Sale7.89200,0001,577,0204,593,687Aug 29 04:05 PM
Swisher Daniel N JRPresident and CEOAug 27Option Exercise2.095,00010,450159,073Aug 29 06:02 PM
BJERKHOLT ERICEVP, CFO & Corp. SecretaryAug 27Option Exercise1.7410,00017,40049,994Aug 29 06:04 PM
Misfeldt DaytonDirectorAug 27Sale8.16100,700822,01489,612Aug 29 06:31 PM
Craig Adam REVP, Development & CMOAug 27Sale8.002,55420,43212,723Aug 29 06:05 PM
BJERKHOLT ERICEVP, CFO & Corp. SecretaryAug 27Sale8.0010,00080,00039,994Aug 29 06:04 PM
Swisher Daniel N JRPresident and CEOAug 27Sale8.005,00040,000154,073Aug 29 06:02 PM
BAY CITY CAPITAL LLC10% OwnerAug 27Sale8.16100,700822,0144,793,687Aug 29 04:05 PM
BASKETT FOREST10% OwnerAug 27Sale8.17108,300884,8114,817,733Aug 29 05:39 PM
BARRETT M JAMES10% OwnerAug 27Sale8.17108,300884,8114,817,733Aug 29 05:38 PM
Growth Equity Opportunities Fu10% OwnerAug 27Sale8.17108,300884,8114,817,733Aug 29 05:37 PM
KERINS PATRICK J10% OwnerAug 27Sale8.17108,300884,8114,817,733Aug 29 05:41 PM
KOLLURI KRISHNA KITTU10% OwnerAug 27Sale8.17108,300884,8114,817,733Aug 29 05:41 PM
DRANT RYAN D10% OwnerAug 27Sale8.17108,300884,8114,817,733Aug 29 05:40 PM
BARRIS PETER J10% OwnerAug 27Sale8.17108,300884,8114,817,733Aug 29 05:39 PM
Growth Equity Opportunities Fu10% OwnerAug 12Sale6.7635,540240,1904,926,033Aug 12 05:39 PM
BARRETT M JAMES10% OwnerAug 12Sale6.7635,540240,1904,926,033Aug 12 05:41 PM
DRANT RYAN D10% OwnerAug 12Sale6.7635,540240,1904,926,033Aug 12 05:44 PM
BASKETT FOREST10% OwnerAug 12Sale6.7635,540240,1904,926,033Aug 12 05:44 PM
Misfeldt DaytonDirectorAug 12Sale6.7737,100251,23091,495Aug 12 08:49 PM
BARRIS PETER J10% OwnerAug 12Sale6.7635,540240,1904,926,033Aug 12 05:44 PM
KOLLURI KRISHNA KITTU10% OwnerAug 12Sale6.7635,540240,1904,926,033Aug 12 05:45 PM
KERINS PATRICK J10% OwnerAug 12Sale6.7635,540240,1904,926,033Aug 12 05:44 PM
BAY CITY CAPITAL LLC10% OwnerAug 12Sale6.7737,100251,2304,894,387Aug 12 05:54 PM
BAY CITY CAPITAL LLC10% OwnerAug 11Sale6.9031,600218,1034,931,487Aug 12 05:54 PM
Misfeldt DaytonDirectorAug 11Sale6.9031,600218,10392,189Aug 12 08:49 PM
Misfeldt DaytonDirectorAug 08Sale6.62675,0004,468,56892,780Aug 12 08:49 PM
BAY CITY CAPITAL LLC10% OwnerAug 08Sale6.62675,0004,468,5684,963,087Aug 12 05:54 PM
KERINS PATRICK J10% OwnerAug 08Sale6.62675,0004,468,5684,961,573Aug 12 05:44 PM
KOLLURI KRISHNA KITTU10% OwnerAug 08Sale6.62675,0004,468,5684,961,573Aug 12 05:45 PM
BARRIS PETER J10% OwnerAug 08Sale6.62675,0004,468,5684,961,573Aug 12 05:44 PM
BASKETT FOREST10% OwnerAug 08Sale6.62675,0004,468,5684,961,573Aug 12 05:44 PM
DRANT RYAN D10% OwnerAug 08Sale6.62675,0004,468,5684,961,573Aug 12 05:44 PM
BARRETT M JAMES10% OwnerAug 08Sale6.62675,0004,468,5684,961,573Aug 12 05:41 PM
Growth Equity Opportunities Fu10% OwnerAug 08Sale6.62675,0004,468,5684,961,573Aug 12 05:39 PM
Swisher Daniel N JRPresident and CEOMay 16Option Exercise2.0924,38950,973152,406May 19 05:11 PM